genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Cell Signaling
Amino Acid That Delivers “Slow Down” Signal to Brain May Contribute…
Cancer
Preventing Metastasis with a STING
Artificial Intelligence
One AI Tool Bests Another in Enzyme Prediction Match
Cancer
How Incurable Melanoma Resists Treatment
AgBio
Food For Thought: Final Report from the AGBT Ag Meeting
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Base Editing
One-Time Treatment: Base Editing Shows Promise vs. SMA
Drug Delivery
Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…
Bioprocessing
Polymer Formulation to Improve Existing Antibiotics
Bioprocessing
Key Consideration for Going Digital
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Topics
Genome Editing
Genome Editing
CRISPR-Cas9
Gene Therapy
Synthetic Biology
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Genome Editing
Successful Step Made toward Synthetic Genomes
Genome Editing
Oxford BioMedica to Obtain $250K to Support Gene Therapy for Stargardt Disease
Genome Editing
IDT Purchases VH Bio’s Oligo Segment
Genome Editing
Scientists Create Targeted Knockout Rats Using Sangamo’s Zinc Finger Nuclease Technology
Genome Editing
DNA2.0 Reveals Intricacies Involved in Optimized Gene Design
Genome Editing
Gene-Synthesis Firms Set Up Biosecurity Protocol
Genome Editing
$25M NSF Center Set Up to Investigate Complex Biological Systems
Genome Editing
Ark Pulls MAA Covering Gene-Based Therapy for Brain Cancer
Genome Editing
Takara Bio Taps University of Pennsylvania to Help Advance HIV Gene...
Genome Editing
Sigma-Aldrich to Provide Gene Synthesis Services to Gene Oracle
Genome Editing
Sigma-Aldrich and Sangamo Biosciences Broaden Agreement Related to Zinc-Finger Technology
Genome Editing
DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from...
Genome Editing
First Replicating Cell Driven by Synthetic Genome Created by Venter Institute
Genome Editing
The Status of U.S. and European Government Funding for Synthetic Biology
Genome Editing
GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal
1
2
3
...
160
Page 1 of 160
Scroll Up
![The U.S. has invested over two and a half times more than the EU and three European countries. [© Orlando Florin Rosu - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June8_2010_18168316_DNAMadeofMoneyAgainstBlueSky_ReportonSynBioFunding3930642484-324x160.jpg "The Status of U.S. and European Government Funding for Synthetic Biology")
